Nurix Therapeutics Inc’s recent filing unveils that its Chief Legal Officer Ring Christine unloaded Company’s shares for reported $82250.0 on Nov 04 ’24. In the deal valued at $25.00 per share,3,290 shares were sold. As a result of this transaction, Ring Christine now holds 28,084 shares worth roughly $0.64 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, CHRISTINE RING bought 3,290 shares, generating $80,506 in total proceeds.
Before that, Ring Christine sold 5,760 shares. Nurix Therapeutics Inc shares valued at $139,867 were divested by the Chief Legal Officer at a price of $24.28 per share. As a result of the transaction, Ring Christine now holds 28,084 shares, worth roughly $0.64 million.
UBS initiated its Nurix Therapeutics Inc [NRIX] rating to a Buy in a research note published on October 24, 2024; the price target was $35. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. Truist started covering the stock on July 31, 2024. It rated NRIX as “a Buy”.
Price Performance Review of NRIX
On Friday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock fall -14.67% to $22.92. Over the last five days, the stock has lost -16.17%. Nurix Therapeutics Inc shares have risen nearly 122.09% since the year began. Nevertheless, the stocks have risen 255.35% over the past one year. While a 52-week high of $29.56 was reached on 11/11/24, a 52-week low of $5.65 was recorded on 01/29/24. SMA at 50 days reached $24.54, while 200 days put it at $18.67.
Levels Of Support And Resistance For NRIX Stock
The 24-hour chart illustrates a support level at 21.66, which if violated will result in even more drops to 20.40. On the upside, there is a resistance level at 25.40. A further resistance level may holdings at 27.88. The Relative Strength Index (RSI) on the 14-day chart is 38.26, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.25, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 99.40%. Stochastics %K at 38.71% indicates the stock is a holding.
How much short interest is there in Nurix Therapeutics Inc?
A steep rise in short interest was recorded in Nurix Therapeutics Inc stocks on 2024-10-31, growing by 0.38 million shares to a total of 9.46 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 9.08 million shares. There was a rise of 4.02%, which implies that there is a positive sentiment for the stock.
